23.03
Veracyte Inc 주식(VCYT)의 최신 뉴스
What analysts say about Veracyte Inc. stockUnrivaled growth potential - jammulinksnews.com
What drives Veracyte Inc. stock priceExceptional stock performance - Autocar Professional
Are Veracyte, Inc.'s (NASDAQ:VCYT) Fundamentals Good Enough to Warrant Buying Given The Stock's Recent Weakness? - simplywall.st
Is Veracyte Inc. a good long term investmentHigh-margin investment plays - Autocar Professional
Veracyte Inc. Stock Analysis and ForecastFree Daily Trading Room Entry - jammulinksnews.com
Principal Financial Group Inc. Raises Holdings in Veracyte, Inc. (NASDAQ:VCYT) - Defense World
When is the best time to buy Veracyte Inc. stockMinimized Risk Maximum Return - Newser
Will Veracyte Inc. stock split in the near futureBreakout Momentum Stocks - Newser
Veracyte, Inc. (NASDAQ:VCYT) Given Consensus Rating of “Moderate Buy” by Brokerages - Defense World
Veracyte to Release Second Quarter 2025 Financial Results on August 6, 2025 - Lelezard
Should You Continue to Hold Veracyte Stock in Your Portfolio Now? - Yahoo Finance
How Veracyte Inc. stock performs during market volatilityPortfolio Boosting Stock Alerts - Newser
Why Veracyte Inc. stock attracts strong analyst attentionReal Chart Play - Newser
What makes Veracyte Inc. stock price move sharplyTop Performer Shortlist - Newser
Veracyte, Inc. (NASDAQ:VCYT) Shares Sold by Teacher Retirement System of Texas - Defense World
Allspring Global Investments Holdings LLC Purchases 4,792 Shares of Veracyte, Inc. (NASDAQ:VCYT) - Defense World
Veracyte Announces that Multiple Afirma GRID Studies Will Be Presented at ENDO 2025 - BioSpace
Veracyte's Afirma GRID Studies at ENDO 2025: A Paradigm Shift in Thyroid Cancer Diagnostics and Personalized Medicine - AInvest
Veracyte, Inc. Announces Multiple Afirma Grid Studies Will Be Presented At Endo 2025 - MarketScreener
Veracyte's Afirma GRID: Pioneering Precision Oncology and Driving Sustainable Growth - AInvest
Wealth Enhancement Advisory Services LLC Grows Holdings in Veracyte, Inc. (NASDAQ:VCYT) - Defense World
Veracyte Q3 2024 slides: Revenue surges 29%, guidance raised for third time By Investing.com - Investing.com South Africa
Veracyte Q3 2024 slides: Revenue surges 29%, guidance raised for third time - Investing.com Canada
Veracyte's Russell 2000 Growth Index Inclusion: A Catalyst for Liquidity and Institutional Momentum - AInvest
Veracyte: A Hidden Gem in Precision Diagnostics Amid Index Exclusion - AInvest
Wall Street Zen Downgrades Veracyte (NASDAQ:VCYT) to Hold - Defense World
Veracyte exploring external buyers for divestiture of French unit’s activities - TipRanks
GAMMA Investing LLC Purchases 18,840 Shares of Veracyte, Inc. (NASDAQ:VCYT) - Defense World
Veracyte shareholders approve 2.5 million share increase to equity plan - Investing.com
Veracyte shareholders approve 2.5 million share increase to equity plan By Investing.com - Investing.com India
Insider Sell: Karin Eastham Sells Shares of Veracyte Inc (VCYT) - GuruFocus
Recent 3.7% Pullback Isn't Enough to Hurt Long-term Veracyte (NASDAQ:VCYT) Shareholders, They're Still up 56% Over 3 Years - 富途牛牛
Veracyte, Inc.'s (NASDAQ:VCYT) Shares Lagging The Industry But So Is The Business - simplywall.st
Veracyte (VCYT) Fell Despite Reporting Revenue Growth and Improved Profitability - Insider Monkey
자본화:
|
볼륨(24시간):